News & Views
Lab21 Appoints Fraser Logue
Apr 20 2012
Lab21 Ltd, a global specialist in personalised medicine and clinical diagnostics has appointed Fraser Logue as Group Director of Quality, Regulatory Affairs & Operations Excellence based in the UK. Dr Logue served two decades in divisions of Abbott Laboratories, most recently as Division Vice President World Wide Manufacturing for Abbott Diabetes Care, moving from Division Vice President European Operations. He previously served as Operations Director for Abbott Diagnostics Division Ireland, Director of Quality & Regulatory and Marketing Manager for Abbott Diagnostics Division in Germany.
Graham Mullis, CEO of Lab21, said: “I am delighted to have someone of Fraser’s experience join Lab21, especially at a time when we expect to see significant organic growth during the next few years. His senior level international management experience and operations capabilities will ensure Lab21 will meet the demands of increasing sales, entering new markets including the US and the launch of new products.” Dr Logue said: “Lab21 has achieved remarkable progress within the past 4 years, growing five times in size. I am looking forward to working with and contributing to the future success of Lab21.”
Digital Edition
LMUK 49.7 Nov 2024
November 2024
News - Research & Events News - News & Views Articles - They’re burning the labs... Spotlight Features - Incubators, Freezers & Cooling Equipment - Pumps, Valves & Liquid Hand...
View all digital editions
Events
Nov 11 2024 Dusseldorf, Germany
Nov 12 2024 Cologne, Germany
Nov 12 2024 Tel Aviv, Israel
Nov 18 2024 Shanghai, China
Nov 20 2024 Karachi, Pakistan